MetLife Investment Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Buy |
15,218
+4,431
| +41% | +$36K | ﹤0.01% | 2434 |
|
|
2025
Q1 | $75.9K | Sell |
10,787
-3,726
| -26% | -$26.2K | ﹤0.01% | 2627 |
|
|
2024
Q4 | $108K | Buy |
+14,513
| New | +$108K | ﹤0.01% | 2586 |
|
|
2023
Q2 | – | Sell |
-7,378
| Closed | -$27.9K | – | 2968 |
|
|
2023
Q1 | $27.9K | Sell |
7,378
-7,495
| -50% | -$28.3K | ﹤0.01% | 2761 |
|
|
2022
Q4 | $96.4K | Hold |
14,873
| – | – | ﹤0.01% | 2608 |
|
|
2022
Q3 | $132K | Buy |
14,873
+3,034
| +26% | +$27K | ﹤0.01% | 2540 |
|
|
2022
Q2 | $118K | Sell |
11,839
-3,171
| -21% | -$31.6K | ﹤0.01% | 2645 |
|
|
2022
Q1 | $174K | Buy |
15,010
+12,372
| +469% | +$143K | ﹤0.01% | 2443 |
|
|
2021
Q4 | $29.3K | Sell |
2,638
-7,356
| -74% | -$81.7K | ﹤0.01% | 2480 |
|
|
2021
Q3 | $92.1K | Buy |
+9,994
| New | +$92.1K | ﹤0.01% | 2473 |
|
|
2021
Q1 | – | Sell |
-12,181
| Closed | -$132K | – | 2326 |
|
|
2020
Q4 | $132K | Buy |
12,181
+78
| +0.6% | +$846 | ﹤0.01% | 2176 |
|
|
2020
Q3 | $118K | Hold |
12,103
| – | – | ﹤0.01% | 2143 |
|
|
2020
Q2 | $96.3K | Hold |
12,103
| – | – | ﹤0.01% | 2267 |
|
|
2020
Q1 | $105K | Hold |
12,103
| – | – | ﹤0.01% | 2047 |
|
|
2019
Q4 | $137K | Buy |
12,103
+6,649
| +122% | +$75.2K | ﹤0.01% | 2176 |
|
|
2019
Q3 | $59.3K | Sell |
5,454
-8,556
| -61% | -$93K | ﹤0.01% | 2323 |
|
|
2019
Q2 | $131K | Hold |
14,010
| – | – | ﹤0.01% | 2256 |
|
|
2019
Q1 | $172K | Hold |
14,010
| – | – | ﹤0.01% | 2053 |
|
|
2018
Q4 | $166K | Hold |
14,010
| – | – | ﹤0.01% | 2010 |
|
|
2018
Q3 | $202K | Hold |
14,010
| – | – | ﹤0.01% | 2075 |
|
|
2018
Q2 | $209K | Hold |
14,010
| – | – | ﹤0.01% | 1900 |
|
|
2018
Q1 | $183K | Hold |
14,010
| – | – | ﹤0.01% | 1936 |
|
|
2017
Q4 | $177K | Buy |
+14,010
| New | +$177K | ﹤0.01% | 1992 |
|